Who owns the PIONEERING NEURONAL HEALTH trademark?

The PIONEERING NEURONAL HEALTH trademark is owned by Protagenic Therapeutics, Inc..

What class is the PIONEERING NEURONAL HEALTH trademark registered in?

The PIONEERING NEURONAL HEALTH trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for PIONEERING NEURONAL HEALTH?

The USPTO serial number for PIONEERING NEURONAL HEALTH is 97160401.

What is the registration number for PIONEERING NEURONAL HEALTH?

PIONEERING NEURONAL HEALTH is registered under USPTO registration number 7589135.

PIO

USPTO Trademark Record

REGISTERED

PIONEERING NEURONAL HEALTH

SN 97160401·Reg 7589135·Filed Dec 07, 2021

Owner Protagenic Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

PIONEERING NEURONAL HEALTH (Serial No. 97160401), Registration No. 7589135, is a registered US trademark filed on Dec 07, 2021 by Protagenic Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 03, 2030

Mark Intelligence

PIONEERING NEURONAL HEALTH (Reg. #7589135) is a registered US trademark that has been protecting its owner, Protagenic Therapeutics, Inc., since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 07, 2021

SERIAL

97160401

REG#

7589135

REGISTERED

Dec 03, 2024

Owner

Applicant

Protagenic Therapeutics, Inc.

Entity

Corporation

State

Address

149 Fifth Avenue, Suite 500, New York, NY, 10010

Country

Attorney

NameErik M. Pelton

Address

PO BOX 100637, ARLINGTON, VA 22210, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 07, 2021

Serial Number97160401

Registration No.7589135

Registration DateDec 03, 2024

Status DateDec 03, 2024

Published for OppositionMar 21, 2023

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Aug 29, 2023

First use in commerce: Aug 29, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

36 events

REGISTERED-PRINCIPAL REGISTER

Dec 03, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 03, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Feb 16, 2024

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 13, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 12, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

SOU EXTENSION 1 GRANTED

Feb 10, 2024

SOU EXTENSION 1 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 10, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Feb 10, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS PETITION TO REVIVE RECEIVED

Jan 22, 2024

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jan 22, 2024

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Jan 22, 2024

NOTICE OF REVIVAL - E-MAILED

SOU EXTENSION RECEIVED WITH TEAS PETITION

Jan 22, 2024

SOU EXTENSION RECEIVED WITH TEAS PETITION

TEAS STATEMENT OF USE RECEIVED

Jan 22, 2024

TEAS STATEMENT OF USE RECEIVED

NOTICE OF REVIVAL - E-MAILED

Jan 22, 2024

NOTICE OF REVIVAL - E-MAILED

USE AMENDMENT FILED

Jan 22, 2024

USE AMENDMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 18, 2023

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Dec 18, 2023

ABANDONMENT - NO USE STATEMENT FILED

SOU EXTENSION 1 FILED

Nov 16, 2023

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 16, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 21, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 21, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 01, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 14, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 06, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 05, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 05, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 20, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Sep 20, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 20, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Sep 20, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 20, 2022

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Sep 20, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 14, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 13, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 10, 2021

NEW APPLICATION ENTERED

PIONEERING NEURONAL HEALTH

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Protagenic Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Erik M. Pelton

Resources

Company